In flux - Researcher AstraZeneca Employee Review

3.0
Jul 21, 2013
Recommend
CEO approval
Business Outlook

Pros

Some good science is being done. Some departments do well.

Cons

Future direction is shareholder-driven. Wasting money on a prestigious move to Cambridge, UK that will presumably save the future of AZ. Some departments have been subject to change year on year - no wonder they do badly.

Explore other reviews about AstraZeneca

5.0
Jun 25, 2026
Recommend
CEO approval
Business Outlook

Pros

Good products, great oncology pipeline

Cons

Global leaders moving to US that have limited understanding of US environment

4.0
Jun 29, 2026
Recommend
CEO approval
Business Outlook

Pros

Lots to learn with multiple launches and focus on AI

Cons

heavy middle layer slows down decision making

See reviews by: Helpful|Rating|Date|All